Bulletin 2011/10 - European Patent Office
10.02.2013 • Views
Share Embed Flag

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

Bulletin 2011/10 - European Patent Office

SHOW MORE
SHOW LESS
ePAPER READ
DOWNLOAD ePAPER
application.epo.org

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

START NOW

(C07D) II.1(1)<br />

• SUBSTITUTED PYRANO [2, 3 - B]PYRI-<br />

DINE DERIVATIVES AS CANNABINOID-1<br />

RECEPTOR MODULATORS<br />

• DÉRIVÉS DE PYRANO [2, 3 - B]PYRIDINE<br />

SUBSTITUÉE EN TANT QUE MODULA-<br />

TEURS DU RÉCEPTEUR DU CANNABI-<br />

NOÏDE-1<br />

(73) Merck Sharp & Dohme Corp., 126 East<br />

Lincoln Avenue, Rahway, NJ 07065, US<br />

(72) DEBENHAM, John, S., Rahway, New Jersey<br />

07065-0907, US<br />

HALE, Jeffrey, J., Rahway, New Jersey<br />

07065-0907, US<br />

HUO, Pei, Rahway, New Jersey 07065-0907,<br />

US<br />

MADSEN-DUGGAN, Christina, B., Rahway,<br />

New Jersey 07065-0907, US<br />

WALSH, Thomas, F., Rahway, New Jersey<br />

07065-0907, US<br />

YAN, Lin, Rahway, New Jersey 07065-0907,<br />

US<br />

(74) Buchan, Gavin MacNicol, et al, Merck Sharp<br />

& Dohme Limited <strong>European</strong> <strong>Patent</strong> Department<br />

Hertford Road, Hoddesdon Hertfordshire<br />

EN11 9BU, GB<br />

C07D 491/16 → (51) C07D 491/052<br />

(51) C07D 495/02 (11) 2 176 269 B1<br />

(25) En (26) En<br />

(21) 08773248.3 (22) 08.07.2008<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HR HU IE IS IT LI LT LU LV MC MT NL<br />

NO PL PT RO SE SI SK TR<br />

(43) 21.04.20<strong>10</strong><br />

(86) CZ 2008/000079 08.07.2008<br />

(87) WO 2009/006859 2009/03 15.01.2009<br />

(30) 09.07.2007 CZ 20070456<br />

(54) • VERFAHREN ZUR HERSTELLUNG VON<br />

ESSIGSÄURE-5-[2-CYCLOPROPYL-1-(2-<br />

FLUORPHENYL)-2-OXOETHYL]-4,5,6,7-<br />

TETRAHYDROTHIENO[3,2-C]PYRIDIN-2-<br />

YL-ESTER (PRASUGREL)<br />

• A METHOD OF MANUFACTURING 5-[2-<br />

CYCLOPROPYL-1-(2-FLUOROPHENYL)-2-<br />

OXOETHYL]-4,5,6,7- TETRAHY-<br />

DROTHIENO[3,2-C]PYRIDIN-2-YL ACET-<br />

ATE (PRASUGREL)<br />

• PROCÉDÉ DE FABRICATION D'ACÉTATE<br />

DE 5-[2-CYCLOPROPYL-1-(2-FLUORO-<br />

PHÉNYL)-2-OXOÉTHYL]-4,5,6,7-TÉTRA-<br />

HYDROTHIÉNO[3,2-C]PYRIDIN-2-YLE<br />

(PRASUGREL)<br />

(73) Zentiva, k.s., U kabelovny 130, Dolni<br />

Mecholupy <strong>10</strong>2 37 Praha <strong>10</strong>, CZ<br />

(72) STEPANKOVA, Hana, 282 01 Cesky Brod, CZ<br />

HAJICEK, Josef, 128 00 Praha 2, CZ<br />

(74) Jirotkova, Ivana, et al, Rott, Ruzicka &<br />

Guttmann <strong>Patent</strong>, Trademark and Law <strong>Office</strong><br />

Vinohradskà 37, 120 00 Praha 2, CZ<br />

(51) C07D 495/04 (11) 1 656 381 B1<br />

(25) En (26) En<br />

(21) 04763994.3 (22) 11.08.2004<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PL PT RO SE SI SK<br />

TR<br />

AL HR LT LV MK<br />

(43) 17.05.2006<br />

(86) EP 2004/008989 11.08.2004<br />

(87) WO 2005/016931 2005/08 24.02.2005<br />

(30) 13.08.2003 DE <strong>10</strong>337773<br />

(54) • KRISTALLISATION VON FESTEN FORMEN<br />

VON CLOPIDOGRELADDITIONSSALZEN<br />

• CRYSTALLISATION OF SOLID FORMS OF<br />

CLOPIDOGREL ADDITION SALTS<br />

• CRISTALLISATION DE FORMES SOLIDES<br />

DE SELS D'ADDITION DU CLOPIDOGREL<br />

Europäisches <strong>Patent</strong>blatt<br />

<strong>European</strong> <strong>Patent</strong> <strong>Bulletin</strong><br />

<strong>Bulletin</strong> européen des brevets<br />

(73) Krka, Torvarna Zdravil, D.D., Novo Mesto,<br />

Smarjeska cesta 6, 8501 Novo mesto, SI<br />

(72) KOTAR-JORDAN, Berta, 8311 Kostanjevica<br />

na Krki, SI<br />

SIMONIC, Igor, 8351 Straza, SI<br />

ZUPET, Rok, 1211 Ljubljana, SI<br />

RUZIC, Milos, 3000 Celje, SI<br />

GRCMAN, Marija, 8212 Velika, SI<br />

PECAVAR, Anica, 8000 Novo mesto, SI<br />

(74) UEXKÜLL & STOLBERG, <strong>Patent</strong>anwälte<br />

Beselerstrasse 4, 22607 Hamburg, DE<br />

C07D 495/16 → (51) C07D 491/052<br />

(51) C07D 501/00 (11) 1 554 289 B1<br />

A61K 31/546<br />

(25) En (26) En<br />

(21) 03787771.9 (22) 12.08.2003<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IT LI LU MC NL PT RO SE SI SK<br />

TR<br />

(43) 20.07.2005<br />

(86) EP 2003/008944 12.08.2003<br />

(87) WO 2004/016623 2004/09 26.02.2004<br />

(30) 13.08.2002 AT 12232002<br />

18.<strong>10</strong>.2002 AT 15882002<br />

(54) • EIN CEFDINIR-ZWISCHENPRODUKT<br />

• A CEFDINIR INTERMEDIATE<br />

• INTERMEDIAIRE DE CEFDINIR<br />

(73) SANDOZ AG, Lichtstrasse 35, 4056 Basel,<br />

CH<br />

(72) KREMMINGER, Peter, 6330 Kufstein, AT<br />

WOLF, Siegfried, 6230 Brixlegg, AT<br />

LUDESCHER, Johannes, A-6252 Breitenbach,<br />

AT<br />

(60) 07111390.6 / 1 842 852<br />

(51) C07D 513/04 (11) 1 840 129 B1<br />

C07B 61/00 A61K 31/429<br />

A61P 31/04<br />

(25) Ja (26) En<br />

(21) 06711975.0 (22) 19.01.2006<br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC NL PL PT RO<br />

SE SI SK TR<br />

(43) 03.<strong>10</strong>.2007<br />

(86) JP 2006/300729 19.01.2006<br />

(87) WO 2006/077919 2006/30 27.07.2006<br />

(30) 19.01.2005 JP 2005011923<br />

(54) • IMIDAZOTHIAZOL-DERIVAT UND HER-<br />

STELLUNGSVERFAHREN DAFÜR<br />

• IMIDAZOTHIAZOLE DERIVATIVE AND<br />

METHOD FOR PRODUCING SAME<br />

• DÉRIVÉ D'IMIDAZOTHIAZOLE ET<br />

MÉTHODE DE SYNTHÈSE DUDIT DÉRIVÉ<br />

(73) Meiji Seika Kaisha Ltd., 4-16, Kyobashi 2chome,<br />

Chuo-ku, Tokyo <strong>10</strong>4-8002, JP<br />

SAGAMI CHEMICAL RESEARCH CENTER,<br />

2743-1, Hayakawa, Ayase-shi, Kanagawa<br />

252-1193, JP<br />

(72) SHITARA, Eiki, uhoku-ku, Yokohama-shi,<br />

Kanagawa, 222856, JP<br />

ATSUMI, Kunio, uhoku-ku, Yokohama-shi,<br />

Kanagawa, 222856, JP<br />

AJITO, Keiichi, me, Chuo-ku, Tokyo,<br />

<strong>10</strong>48002, JP<br />

IKEDA, Shinya, -shi, Kanagawa, 2500852, JP<br />

KATOH, Tadashi, i, Miyagi, 9800801, JP<br />

INOUE, Munenori, 30403, JP<br />

NAKATANI, Mari, Shizuoka-ken, JP<br />

(74) Warcoin, Jacques, et al, Cabinet Régimbeau<br />

20, rue de Chazelles, 75847 Paris Cedex 17,<br />

FR<br />

(51) C07D 519/00 (11) 2 024 375 B1<br />

A61P 31/12 A61K 31/55<br />

(25) En (26) En<br />

(21) 07761873.4 (22) 04.05.2007<br />

590<br />

<strong>Patent</strong>e<br />

<strong>Patent</strong>s<br />

Brevets (<strong>10</strong>/<strong>2011</strong>) 09.03.<strong>2011</strong><br />

(84) AT BE BG CH CY CZ DE DK EE ES FI FR GB<br />

GR HU IE IS IT LI LT LU LV MC MT NL PL PT<br />

RO SE SI SK TR<br />

HR<br />

(43) 18.02.2009<br />

(86) US 2007/068209 04.05.2007<br />

(87) WO 2007/136982 2007/48 29.11.2007<br />

(30) 17.05.2006 US 801125 P<br />

19.05.2006 US 802005 P<br />

16.<strong>10</strong>.2006 US 852084 P<br />

14.03.2007 US 894757 P<br />

(54) • CYCLOPROPYL-ANNELIERTE INDOLO-<br />

BENZAZEPINE ALS HCV-NS5B-INHIBITO-<br />

REN<br />

• CYCLOPROPYL FUSED INDOLOBENZAZE-<br />

PINE HCV NS5B INHIBITORS<br />

• INHIBITEURS DE VHC NS5B DE TYPE<br />

INDOLOBENZAZÉPINE FUSIONNÉE À UN<br />

CYCLOPROPYLE<br />

(73) Bristol-Myers Squibb Company, Route 206<br />

and Province Line Road, Princeton, NJ<br />

08543-4000, US<br />

(72) BENDER, John A., Wallingford, Connecticut<br />

06492, US<br />

DING, Min, Wallingford, Connecticut 06492,<br />

US<br />

GENTLES, Robert G., Wallingford, Connecticut<br />

06492, US<br />

HEWAWASAM, Piyasena, Wallingford, Connecticut<br />

06492, US<br />

(74) Reitstötter - Kinzebach, <strong>Patent</strong>anwälte<br />

Sternwartstrasse 4, 81679 München, DE<br />

(51) C07F 5/02 (11) 1 355 9<strong>10</strong> B1<br />

C07F 5/04 C07K 5/078<br />

A61K 38/05 A61K 31/69<br />

A61P 35/00 A61P 29/00<br />

(25) En (26) En<br />

(21) 02709145.3 (22) 25.01.2002<br />

(84) AT BE CH CY DE DK ES FI FR GB GR IE IT LI<br />

LU MC NL PT SE TR<br />

(43) 29.<strong>10</strong>.2003<br />

(86) US 2002/001907 25.01.2002<br />

(87) WO 2002/059130 2002/31 01.08.2002<br />

(30) 25.01.2001 US 264160 P<br />

(54) • FORMULIERUNGEN VON BORSÄURE-<br />

VERBINDUNGEN<br />

• FORMULATION OF BORONIC ACID COM-<br />

POUNDS<br />

• FORMULATION DE COMPOSES D'ACIDE<br />

BORONIQUE<br />

(73) The United States of America, represented by<br />

the Secretary, Department of Health and<br />

Human Services, National Institutes of<br />

Health, <strong>Office</strong> of Technology Transfer, Suite<br />

325, 6011 Executive Boulevard, Rockville,<br />

MD 20852, US<br />

(72) GUPTA, Shanker, Rockville, MD 20850, US<br />

(74) Grünecker, Kinkeldey, Stockmair & Schwanhäusser<br />

Anwaltssozietät, Leopoldstrasse 4,<br />

80802 München, DE<br />

(60) <strong>10</strong>006835.2 / 2 251 344<br />

C07F 5/04 → (51) C07F 5/02<br />

C07F 5/06 → (51) B01J 31/14<br />

C07F 7/08 → (51) C07B 63/02<br />

C07F 7/12 → (51) C07B 63/02<br />

C07F 7/18 → (51) C07B 63/02<br />

C07F 7/18 → (51) C07D 239/42<br />

C07F 7/18 → (51) C09J 183/04<br />

C07F 7/22 → (51) C07B 63/02

logo

products

Resources

Company

Terms of service
Privacy policy
Cookie policy
Cookie settings
Imprint
Change language
Made with love in Switzerland
© 2024 Yumpu.com all rights reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!